Login / Signup

Human Factors Validation of a Wearable, On-Body Infusor for Subcutaneous Administration of Furosemide.

Anthony D AndreJohn F MohrBarbara W CorneliusMatthew M GoodwinCarson P WhitakerBhavini H PatelJessica A HuckleberryMichael D Hassman
Published in: Medical devices (Auckland, N.Z.) (2024)
The subcutaneous furosemide OBI can be safely and effectively used by patients, caregivers, and HCPs, regardless of training.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • endothelial cells
  • newly diagnosed
  • chronic kidney disease
  • palliative care
  • prognostic factors
  • peritoneal dialysis
  • blood pressure